Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs

被引:19
作者
Arellano, C
Philibert, C
Yakan, ENDà
Vachoux, C
Lacombe, O
Woodley, J
Houin, G
机构
[1] Fac Pharmaceut Sci, ENVT, INRA, UPTE,UMR 181,Lab Cinet Xenobiot, F-31062 Toulouse, France
[2] CHU Rangueil, Lab Toxicol & Pharmacocinet Clin, F-31043 Toulouse, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 819卷 / 01期
关键词
dextromethorphan; LC-MS; intestine; metabolism; cytochrome P450;
D O I
10.1016/j.jchromb.2005.01.036
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive and selective liquid chromatography-mass spectrometry (LC-MS) method was developed for the simultaneous assay of dextromethorphan and its metabolites in tissue culture medium and its intestinal metabolism studied with the rat everted gut sac model. The method was validated in the concentration range of 0.1-2.5 mu M (27.1 ng/mL-0.677 mu g/mL) for dextromethorphan and 0.005-0.5 mu M for dextrorphan and 3-methoxymorphinan (1.28 ng/mL-0.128 mu g/mL) and 3-hydroxymorphinan (1.22 ng/mL-0.122 mu g/mL). The limits of quantification (LOQ) were 0.0025 mu M (12.5 fmoles, 3.4 pg, 5 mu L injected) for dextromethorphan; 0.0025 mu M for dextrorphan, 3-methoxymorphinan (24.9 fmoles, 6.4 pg injected), and 3-hydroxymorphinan (25.1 fmoles, 6.1 pg injected) with 10 mu L injected. The detection of dextrorphan and 3-methoxymorphinan showed that both the P450 isoforms CYP3A and 2D were active in the intestinal mucosa and metabolised dextromethorphan during its passage across the mucosa. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 44 条
[11]  
Cornaire G, 2000, ARZNEIMITTEL-FORSCH, V50, P576
[12]   Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level [J].
Cotreau, MM ;
von Moltke, LL ;
Beinfeld, MC ;
Greenblatt, DJ .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 43 (01) :41-54
[13]  
Crowe A, 1999, DRUG METAB DISPOS, V27, P627
[14]   Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4 [J].
Cummins, CL ;
Jacobsen, W ;
Benet, LZ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :1036-1045
[15]   Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues [J].
Debri, K ;
Boobis, AR ;
Edwards, RJ .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (12) :2047-2056
[16]   The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: The role of gut CYP3A and P-glycoprotein [J].
Di Marco, MP ;
Edwards, DJ ;
Wainer, IW ;
Ducharme, MP .
LIFE SCIENCES, 2002, 71 (10) :1149-1160
[17]  
Eichhold TH, 1997, J MASS SPECTROM, V32, P1205
[18]  
FASCO MJ, 1993, MOL PHARMACOL, V43, P226
[19]   A novel testosterone 6β-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro [J].
Fayer, JL ;
Petullo, DM ;
Ring, BJ ;
Wrighton, SA ;
Ruterbories, KJ .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2001, 46 (02) :117-123
[20]   Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery [J].
Hebert, MF .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) :201-214